Different Doses of Rosuvastatin Therapy on Regression of Critical Coronary Atherosclerosis in ACS Patients
NCT02420899
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Acute Coronary Syndrome
Interventions
DRUG:
rosuvastatin
Sponsor
Beijing Friendship Hospital